Addressing cancer health disparities in Detroit
Reducing Cancer Health Disparities in Detroit
This study is looking at how to improve lung cancer treatment for people in Detroit who may not have the same access to care, by exploring how different races respond to certain medications and the side effects they experience, so we can find better ways to help everyone feel better and live healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10684276 on NIH RePORTER |
What this research studies
This research focuses on understanding and reducing cancer health disparities in the underserved population of metropolitan Detroit. It involves two main projects that explore the effectiveness of immune checkpoint inhibitors (ICIs) in lung cancer treatment, particularly how race-specific immune profiles and patient-reported side effects influence treatment outcomes. The research aims to gather data on the unique challenges faced by racially diverse lung cancer patients, including their responses to treatment and quality of life. By engaging with the community and utilizing biospecimens, the study seeks to inform better treatment strategies tailored to these populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients from racially diverse backgrounds living in metropolitan Detroit.
Not a fit: Patients with cancers other than lung cancer or those not residing in the Detroit area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and reduced disparities in lung cancer care for racially diverse populations.
How similar studies have performed: Previous research has shown success in addressing cancer health disparities through community engagement and tailored treatment approaches, making this a promising area of investigation.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Schwartz, Ann G. — Wayne State University
- Study coordinator: Schwartz, Ann G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.